byiShook Opinion
Feb 14, 2025 - 07:25
Covid vaccine maker Moderna posted a mixed fourth-quarter report Friday as sales topped Wall Street's projections, but on steep losses. The post Will Moderna's Retained 2025 Outlook Bolster Its Depressed Shares? appeared first on Investor's Business Daily.
Covid vaccine maker Moderna posted a mixed fourth-quarter report Friday as sales topped Wall Street's projections, but on steep losses.
The post Will Moderna's Retained 2025 Outlook Bolster Its Depressed Shares? appeared first on Investor's Business Daily.